NIH Awards Akonni $300K to Develop System to ID Disease in CSF | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Akonni Biosystems today announced the National Institutes of Health has awarded it $300,000 to develop nucleic acid extraction and microarray-based testing systems for the identification of human disease in cerebrospinal fluid.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.